Published in the Journal of Clinical Oncology, University of Minnesota Medical School researchers led a study that demonstrated the safety of using microbiota transplant therapy (MTT) in patients with acute myeloid leukemia (AML)—a type of blood cancer—and recipients of hematopoietic cell transplantation (HCT).
Leave A Comment